CoChat

The Role of Exercise in the Interplay between Myokines, Hepatokines, Osteokines, Adipokines, and Modulation of Inflammation for Energy Substrate Redistribution and Fat Mass Loss: A Review

Open access
Gonzalez-Gil, Adrian M., Elizondo-Montemayor, Leticia · 2020 · Nutrients

The DOI matches its Crossref record; 292 of the 298 references it cites were found in a registry or an index; 184 of the 393 sources its claims cite were checked for support.

Abstract

Exercise is an effective strategy for preventing and treating obesity and its related cardiometabolic disorders, resulting in significant loss of body fat mass, white adipose tissue browning, redistribution of energy substrates, optimization of global energy expenditure, enhancement of hypothalamic circuits that control appetite-satiety and energy expenditure, and decreased systemic inflammation and insulin resistance. Novel exercise-inducible soluble factors, including myokines, hepatokines, and osteokines, and immune cytokines and adipokines are hypothesized to play an important role in the body's response to exercise. To our knowledge, no review has provided a comprehensive integrative overview of these novel molecular players and the mechanisms involved in the redistribution of metabolic fuel during and after exercise, the loss of weight and fat mass, and reduced inflammation. In this review, we explain the potential role of these exercise-inducible factors, namely myokines, such as irisin, IL-6, IL-15, METRNL, BAIBA, and myostatin, and hepatokines, in particular selenoprotein P, fetuin A, FGF21, ANGPTL4, and follistatin. We also describe the function of osteokines, specifically osteocalcin, and of adipokines such as leptin, adiponectin, and resistin. We also emphasize an integrative overview of the pleiotropic mechanisms, the metabolic pathways, and the inter-organ crosstalk involved in energy expenditure, fat mass loss, reduced inflammation, and healthy weight induced by exercise.

Overview

CoChat Summary

## TL;DR

This narrative review argues that exercise promotes fat-mass loss and metabolic health through a coordinated network of exercise-inducible myokines, hepatokines, osteokines, adipokines, and anti-inflammatory effects. It synthesizes evidence that these factors shift energy substrates away from visceral fat storage and toward skeletal muscle oxidation, while also improving insulin sensitivity and reducing inflammation.

## Key findings

  • Exercise is described as a cornerstone of obesity management, with the paper stating that exercise can reduce visceral adipose tissue (VAT) independently of overall weight change and may be more effective than hypocaloric dietetic interventions.
  • The review highlights several exercise-induced factors as beneficial, including irisin, IL-6, IL-15, METRNL, BAIBA, FGF21, ANGPTL4, follistatin, osteocalcin, and adiponectin; together they are proposed to increase oxidative metabolism, WAT browning, and anti-inflammatory signaling.
  • The paper reports specific numeric effects/examples, including:
  • IL-6 serum levels increasing from “5-fold following 30 min of running at 75% VO2 max” to “100-fold during marathon running.”
  • A murine model overexpressing IL-15 showing visceral fat mass “approximately half” that of controls.
  • An 8-week endurance-training study in healthy adults where increased circulating irisin correlated with visceral fat loss measured by DEXA.
  • A 12-week aerobic exercise intervention in obese, insulin-resistant subjects that decreased fetuin A, hepatic insulin resistance, total body fat, and fasting insulin levels.
  • The authors conclude that repeated exercise bouts and chronic training maintain an anti-inflammatory, insulin-sensitive state that favors healthy weight and fat-mass maintenance.

## Methods

  • Narrative review of the literature, explicitly described as using an “exhaustive literature search in the PubMed database.”
  • Integrative synthesis of clinical and preclinical studies on exercise-responsive organokines and their roles in energy substrate redistribution, fat loss, inflammation, and metabolic health.
  • The paper organizes findings by factor class and mechanism, then proposes an inter-organ crosstalk model summarizing how exercise affects metabolism.

## Limitations

  • The paper states that the topic is broad and that the review is a narrative synthesis; it does not present a new primary dataset.
  • It explicitly says that “more research is needed to corroborate these hypotheses,” and notes that many aspects of these molecules remain “understudied or controversial in humans” (stated in the paper).
  • It also states that most exercise-induced factors have been studied independently and calls for larger human interventional studies measuring multiple organokines before and after acute and chronic exercise.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.3390/nu12061899

Cites

292 of 292 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 Effects of exercise-inducible factors on appetite control. Details in text. Abbreviations: BAIBA: β-Aminoisobutyric acid; EE: Energy expenditure; FGF21: Fibroblast-growth factor 21; FI: Food intake; GLP-1: Glucagon-like peptide 1; IL-6: Interleukin-6; OCN: Osteocalcin. Green arrows represent a stimulatory effect over another mediator; red inhibitor lines represent an inhibitory effect over another mediator; black arrows or inhibitor lines indicate the final physiologic effect of any given mediator, either stimulatory or inhibitory, respectively. Custom image created with Biorender.
Figure 1 Effects of exercise-inducible factors on appetite control. Details in text. Abbreviations: BAIBA: β-Aminoisobutyric acid; EE: Energy expenditure; FGF21: Fibroblast-growth factor 21; FI: Food intake; GLP-1: Glucagon-like peptide 1; IL-6: Interleukin-6; OCN: Osteocalcin. Green arrows represent a stimulatory effect over another mediator; red inhibitor lines represent an inhibitory effect over another mediator; black arrows or inhibitor lines indicate the final physiologic effect of any given mediator, either stimulatory or inhibitory, respectively. Custom image created with Biorender.CC BY · PubMed Central
Figure 2 Effects of exercise-inducible factors on the systemic inflammatory milieu and insulin sensitivity. Details in text. Abbreviations: BAIBA: β-Aminoisobutyric acid; FGF21: Fibroblast growth factor 21; IL-1Ra: Interleukin-1 receptor antagonist; IL-1β: Interleukin-1β; IL-6: Interleukin-6; IL-10: Interleukin-10; IL-15: Interleukin-15 MCP-1: Monocyte chemoattractant protein-1; METRNL: Meteorin-like; OCN: Osteocalcin; TNF-α: Tumor necrosis factor-alpha. Green arrows represent a stimulatory effect over another mediator; red inhibitor lines represent an inhibitory effect over another mediator; black arrows or inhibitor lines indicate the final physiologic effect of any given mediator, either stimulatory or inhibitory, respectively; dotted lines indicate absence of an expected effect, either stimulatory or inhibitory. Custom image created with Biorender.
Figure 2 Effects of exercise-inducible factors on the systemic inflammatory milieu and insulin sensitivity. Details in text. Abbreviations: BAIBA: β-Aminoisobutyric acid; FGF21: Fibroblast growth factor 21; IL-1Ra: Interleukin-1 receptor antagonist; IL-1β: Interleukin-1β; IL-6: Interleukin-6; IL-10: Interleukin-10; IL-15: Interleukin-15 MCP-1: Monocyte chemoattractant protein-1; METRNL: Meteorin-like; OCN: Osteocalcin; TNF-α: Tumor necrosis factor-alpha. Green arrows represent a stimulatory effect over another mediator; red inhibitor lines represent an inhibitory effect over another mediator; black arrows or inhibitor lines indicate the final physiologic effect of any given mediator, either stimulatory or inhibitory, respectively; dotted lines indicate absence of an expected effect, either stimulatory or inhibitory. Custom image created with Biorender.CC BY · PubMed Central
Figure 3 Effects of exercise-inducible factors on WAT “browning”. Details in text. Abbreviations: BAIBA: β-Aminoisobutyric acid; BAT: Brown (and beige) adipose tissue; FGF21: Fibroblast growth factor 21; GLP-1: Glucagon-like peptide 1; IL-6: Interleukin-6; IL-15: Interleukin-15; METRNL: Meteorin-like; OCN: Osteocalcin; SNS: Sympathetic nervous system; WAT: White adipose tissue. Green arrows represent a stimulatory effect over another mediator; red inhibitor lines represent an inhibitory effect over another mediator; black arrows or inhibitor lines indicate the final physiologic effect of any given mediator, either stimulatory or inhibitory, respectively; dotted lines indicate absence of an expected effect, either stimulatory or inhibitory. Custom image created with Biorender.
Figure 3 Effects of exercise-inducible factors on WAT “browning”. Details in text. Abbreviations: BAIBA: β-Aminoisobutyric acid; BAT: Brown (and beige) adipose tissue; FGF21: Fibroblast growth factor 21; GLP-1: Glucagon-like peptide 1; IL-6: Interleukin-6; IL-15: Interleukin-15; METRNL: Meteorin-like; OCN: Osteocalcin; SNS: Sympathetic nervous system; WAT: White adipose tissue. Green arrows represent a stimulatory effect over another mediator; red inhibitor lines represent an inhibitory effect over another mediator; black arrows or inhibitor lines indicate the final physiologic effect of any given mediator, either stimulatory or inhibitory, respectively; dotted lines indicate absence of an expected effect, either stimulatory or inhibitory. Custom image created with Biorender.CC BY · PubMed Central
Figure 4 Effects of exercise-inducible factors on hepatic and SkM FAO, WAT lipolysis, and hepatic lipogenesis. Details in text. *Although SeP is not regulated by exercise, its high concentrations in obesity might impair SkM adaptation to oxidative metabolism. Abbreviations: ANPTL4: Angiopoietin-like 4; BAIBA: β-Aminoisobutyric acid; FAO: Fatty acid oxidation; FFAs: Free fatty acids; FGF21: Fibroblast growth factor 21; IL-6: Interleukin-6; IL-15: Interleukin-15; IR: Insulin resistance; METRNL: Meteorin-like; OCN: Osteocalcin; SeP: Selenoprotein P; TG: Triglycerides; VLDL: Very-low-density lipoprotein. Green arrows represent a stimulatory effect over another mediator; red inhibitor lines represent an inhibitory effect over another mediator; black arrows or inhibitor lines indicate the final physiologic effect of any given mediator, either stimulatory or inhibitory, respectively; dotted lines indicate absence of an expected effect, either stimulatory or inhibitory. Custom image created with Biorender.
Figure 4 Effects of exercise-inducible factors on hepatic and SkM FAO, WAT lipolysis, and hepatic lipogenesis. Details in text. *Although SeP is not regulated by exercise, its high concentrations in obesity might impair SkM adaptation to oxidative metabolism. Abbreviations: ANPTL4: Angiopoietin-like 4; BAIBA: β-Aminoisobutyric acid; FAO: Fatty acid oxidation; FFAs: Free fatty acids; FGF21: Fibroblast growth factor 21; IL-6: Interleukin-6; IL-15: Interleukin-15; IR: Insulin resistance; METRNL: Meteorin-like; OCN: Osteocalcin; SeP: Selenoprotein P; TG: Triglycerides; VLDL: Very-low-density lipoprotein. Green arrows represent a stimulatory effect over another mediator; red inhibitor lines represent an inhibitory effect over another mediator; black arrows or inhibitor lines indicate the final physiologic effect of any given mediator, either stimulatory or inhibitory, respectively; dotted lines indicate absence of an expected effect, either stimulatory or inhibitory. Custom image created with Biorender.CC BY · PubMed Central
Figure 5 An integrated view of the role of exercise training on pathways associated with energy expenditure, fat mass loss, redistribution of energy substrates, adipose tissue reserves, and immunometabolic health: integrated neuroendocrine pathways associated with exercise training that affect global AT reserves and function. Interdependence between the processes of central control of energy balance, WAT browning, inflammation, and insulin sensitivity is highlighted. AT: adipose tissue, ANGPTL4: Angiopoietin-like 4; BAIBA: β-Aminoisobutyric acid; BAT: Brown (and beige) adipose tissue; EE: Energy expenditure; ER: Endoplasmic reticulum; FAO: Fatty acid oxidation; FI: Food intake; FGF21: Fibroblast growth factor 21; GH: Growth hormone; GLP-1: Glucagon-like peptide 1; IL-1Ra: Interleukin-1 receptor antagonist; IL-1β: Interleukin-1β; IL-6: Interleukin-6; IL-10: Interleukin-10 IL-15: Interleukin-15; MCP-1: Monocyte chemoattractant protein-1; METRNL: Meteorin-like; OCN: Osteocalcin; OS: Oxidative stress; ROS: Reactive oxygen species; SNS: Sympathetic nervous system; TNF-α: Tumor necrosis factor alpha; VAT: Visceral adipose tissue. Green arrows represent a stimulatory effect over another mediator; red inhibitor lines represent an inhibitory effect over another mediator; black arrows or inhibitor lines indicate the final physiologic effect of any given mediator, either stimulatory or inhibitory, respectively; blue arrow or inhibitor lines indicate the consequence of a process as a whole, either stimulatory or inhibitory, respectively; orange inhibitor lines indicate the final processes in the control of fat mass; dotted lines indicate absence of an expected effect, either stimulatory or inhibitory. Custom image created with Biorender.
Figure 5 An integrated view of the role of exercise training on pathways associated with energy expenditure, fat mass loss, redistribution of energy substrates, adipose tissue reserves, and immunometabolic health: integrated neuroendocrine pathways associated with exercise training that affect global AT reserves and function. Interdependence between the processes of central control of energy balance, WAT browning, inflammation, and insulin sensitivity is highlighted. AT: adipose tissue, ANGPTL4: Angiopoietin-like 4; BAIBA: β-Aminoisobutyric acid; BAT: Brown (and beige) adipose tissue; EE: Energy expenditure; ER: Endoplasmic reticulum; FAO: Fatty acid oxidation; FI: Food intake; FGF21: Fibroblast growth factor 21; GH: Growth hormone; GLP-1: Glucagon-like peptide 1; IL-1Ra: Interleukin-1 receptor antagonist; IL-1β: Interleukin-1β; IL-6: Interleukin-6; IL-10: Interleukin-10 IL-15: Interleukin-15; MCP-1: Monocyte chemoattractant protein-1; METRNL: Meteorin-like; OCN: Osteocalcin; OS: Oxidative stress; ROS: Reactive oxygen species; SNS: Sympathetic nervous system; TNF-α: Tumor necrosis factor alpha; VAT: Visceral adipose tissue. Green arrows represent a stimulatory effect over another mediator; red inhibitor lines represent an inhibitory effect over another mediator; black arrows or inhibitor lines indicate the final physiologic effect of any given mediator, either stimulatory or inhibitory, respectively; blue arrow or inhibitor lines indicate the consequence of a process as a whole, either stimulatory or inhibitory, respectively; orange inhibitor lines indicate the final processes in the control of fat mass; dotted lines indicate absence of an expected effect, either stimulatory or inhibitory. Custom image created with Biorender.CC BY · PubMed Central

Verification

Claims the paper makes

139 Valid · 13 Not valid · 111 Not checked · 108 Own results and interpretations

206 more claims · 80 with their cited sources checked

Create a free account to see all 371 claims and to verify the 2 references still open.

See all claims — free account
  • It may state two separate claims as one. 139
  • Probably not a substantial claim. 26

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

21 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Self-check results appear here once an independent check has confirmed them.

Cited works that were retracted

Works this paper cites that were later retracted, from the retraction notices publishers deposit. Major when the notice came out before this paper was published.

1 of 1

Citations

Cites

1 retracted

Research works printed but not linked: 2

  1. Ferrier, D.R. (2014). The feed-fast cycle. Lippincott’s Illustrated Reviews: Biochemistry, Wolters-Kluwer Health|Lippincott Williams & Wilkins. [6th ed.].
  2. Feingold, K.R., Anawalt, B., and Boyce, A. (2020, March 09). Exercise treatment of obesity, Endotext [Internet], Available online: https://www.ncbi.nlm.nih.gov/books/NBK278961/.

Cited by

See all 278

Metadata

Authors
Gonzalez-Gil, A. M., & Elizondo-Montemayor, L.
Affiliations
Tecnologico de Monterrey, Escuela de Medicina y Ciencias de la Salud, Ave. Morones Prieto 3000, Monterrey N.L. 64710, Mexico
Venue
Nutrients
Publisher
MDPI AG
Published
2020-06-26
Volume
12
Issue
6
Pages
1899
ISSN
2072-6643 (ISSN-L)
OpenAlex
W3037417136
Cited by
278
References
298
Citations by year
2026: 32 · 2025: 48 · 2024: 56 · 2023: 57 · 2022: 49 · 2021: 30 · 2020: 6
FWCI
4.37
Type
journal article
Language
en
Open access
Locations
  • Nutrients (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Topics
  • Health Sciences › Medicine › Physiology (medical) › Exercise and Physiological Responses
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
  • Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
Keywords
physical activity, myokines, hepatokines, osteokines, adipokines, inflammation, obesity, fat loss, energy expenditure, white adipose tissue browning, irisin, FGF21, selenoprotein P, fetuin-A, ANGPTL4, follistatin, osteocalcin, leptin, adiponectin, resistin, myostatin, organ crosstalk, insulin resistance
MeSH terms
Adipose Tissue, Animals, Appetite Regulation, Body Composition, Bone and Bones, Energy Metabolism, Humans, Liver, Obesity, Peptides, Weight Loss, Exercise, Muscle, Skeletal, Peptide Hormones, Lipid Metabolism, Metabolic Networks and Pathways, Adipokines

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-09, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-09 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.